North of the Border, Liquid Locoweed is Legal | Seven Days Vermont

Please support our work!

 Donate  Advertise
Cannabis

North of the Border, Liquid Locoweed is Legal 

Local Matters

Published April 27, 2005 at 4:00 p.m. | Updated October 5, 2017 at 10:01 p.m.

Last week the cover story of Seven Days addressed whether Vermont ought to follow up last year's medical marijuana legislation with further decriminalization of pot possession. Both notions are still considered radical by legislators in many states -- only about a dozen have approved the use of medical marijuana for patients with terminal or chronic illnesses. Meanwhile, on April 19, the Canadian government delivered a body blow to the U.S. government's opposition to medical marijuana. It approved prescription sale of a natural marijuana extract to treat pain and other symptoms caused by multiple sclerosis.

Sativex, produced by GW Pharmaceuticals in Britain, brings the medical marijuana debate full circle. Though the technology has advanced in 70 years, this product is a direct descendent of the marijuana extracts and tinctures that were a standard part of the medical armamentarium until the late 1930s -- universally recognized as being safe and effective for certain conditions. These products were taken away from patients and doctors as a result of the prohibition on marijuana that began in 1937, despite the public opposition of the American Medical Association.

In short, the Canadian government has just certified that virtually everything our own government has been telling us about marijuana is wrong. In defiance of a large and growing pile of scientific studies, this administration still claims that marijuana has no medical value. White House Drug Czar John Walters has even compared medical marijuana to "medicinal crack."

Make no mistake: Sativex is liquid marijuana. It is nothing like Marinol, the synthetic THC pill sold in the U.S. and sometimes falsely touted as an adequate substitute for marijuana. Sativex is a whole-plant extract, containing the rich variety of naturally occurring compounds called cannabinoids that are unique to marijuana. It also contains trace elements of other compounds contained in the plant, which scientists believe contribute to its therapeutic value.

On its website GW Pharmaceuticals explains, "We believe very strongly that many of the advantages of using the whole plant come from the inclusion of other components of cannabis [marijuana]," not just THC. "In the cannabis plant, it appears that some of the components added together give better effect. Some components seem to work to counteract some of the side effects of others, and the whole plant is generally well tolerated by humans."

Studies have shown significant effect against pain and other symptoms caused by multiple sclerosis and other debilitating conditions. Over 600 patient-years of research have established a remarkable record of safety. Sativex is to marijuana as a cup of coffee is to coffee beans. If Sativex is safe and effective, marijuana is safe and effective.

Rob Kampia is executive director of the Marijuana Policy Project in Washington, D.C.

candles in the shape of a 29

Light Our Candles?

Seven Days just turned 29. Help us celebrate and make it to 30!

Donate today and become a Super Reader. We’re counting on generous people like you for 129 gifts by September 27.

New: Become a monthly donor or increase your existing recurring donation today and we’ll send you a framable print of our once-in-a-lifetime eclipse cover photographed by James Buck.

Got something to say? Send a letter to the editor and we'll publish your feedback in print!

About The Author

Rob Kampia

Comments


Comments are closed.

From 2014-2020, Seven Days allowed readers to comment on all stories posted on our website. While we've appreciated the suggestions and insights, right now Seven Days is prioritizing our core mission — producing high-quality, responsible local journalism — over moderating online debates between readers.

To criticize, correct or praise our reporting, please send us a letter to the editor or send us a tip. We’ll check it out and report the results.

Online comments may return when we have better tech tools for managing them. Thanks for reading.

Keep up with us Seven Days a week!

Sign up for our fun and informative
newsletters:

All content © 2024 Da Capo Publishing, Inc. 255 So. Champlain St. Ste. 5, Burlington, VT 05401

Advertising Policy  |  Privacy Policy  |  Contact Us  |  About Us  |  Help
Website powered by Foundation